Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day everyone and welcome to today’s Avadel Pharmaceuticals ...

Q3 2024 Earnings Call Transcript November 6, 2024 Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.918 ...

Adjusted Net Income Guidance: $1.275 billion to $1.35 billion. Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) reported strong growth across its commercial portfolio, with Xywav and Epidiolex posting ...

November 7, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company ...

Neimeth International Pharmaceuticals Plc has announced the appointment of Ms. Patricia Aderibigbe and Mr. Adeyemi Odusanya as Independent Non-Executive Directors.

Impax Asset Management Group plc raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 56.1% in the third quarter, according to its most recent 13F filing ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...